Phase Forward (NASDAQ: PFWD), a leading provider of data management
solutions for clinical trials and drug safety, today announced its chief
financial officer, Chris Menard, and its vice president of corporate
development, Martin Young, will present at the 11th Annual
Pacific Crest Technology Leadership Forum at the Sonnenalp Resort in
Vail, Colorado.
The Phase Forward presentation is scheduled for Tuesday, August 11, 2009
at 9:30 a.m. MT. The presentation will be webcast live and will be
available by visiting the Investors section of the company’s website at www.phaseforward.com.
The webcast will be archived on the company’s website for 30 days after
the conference ends.
About Phase Forward
Phase Forward is a leading provider of integrated data management
solutions for clinical trials and drug safety. Phase Forward’s products
and services have been utilized in over 10,000 clinical trials involving
more than 1,000,000 clinical trial study participants at over 290
organizations and regulatory agencies worldwide including: AstraZeneca,
Boston Scientific, Dana-Farber Cancer Institute, Eli Lilly, the U.S.
Food and Drug Administration, GlaxoSmithKline, Harvard Clinical Research
Institute, Merck Serono, Novartis, Novo Nordisk, PAREXEL International,
Procter & Gamble, Quintiles, sanofi-aventis, Schering-Plough Research
Institute, Servier, Tibotec and the U.K. Medicines and Healthcare
Products Regulatory Agency. Additional information about Phase Forward
is available at www.phaseforward.com.
Public Relations
CHEN PR, Inc.
Barbara
Heffner, 508-397-1138
bheffner@chenpr.com
or
Investor
Relations
ICR
Timothy Dolan, 617-956-6727
tdolan@icrinc.com
